AGI.do

Products

What will AGI do for Altanserin tartrate?

This classification denotes a serotonin antagonist with the molecular formula C22H22FN3O2S.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9P204CHE8J, chemically known as 4(1h)-quinazolinone, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-2,3-dihydro-2-thioxo-, (r-(r*,r*))-2,3-dihydroxybutanedioate but more generally known as altanserin tartrate, which bears US NIH Compound Identifier 3033676. Most nations, for tariff and trade purposes, schedule altanserin tartrate under HS 29335995 and SITC 51576. As of Q4 2014, ALTANSERIN TARTRATE remains US FDA's Preferred Term for this commodity. Altanserin tartrate bears US NLM identifiers UMLS ID C2698070 and NCI Concept Code C79965. SMILES: C1CCC2C(C1)C(=O)N(C(=S)[NH]2)CCN3CCC(CC3)C(=O)C4CCC(CC4)F.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

How AGI delivers it

Four ways AGI delivers for Altanserin tartrate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Altanserin tartrate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Altanserin tartrate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Altanserin tartrate connects

measured by

  • Compound Puritymodel
  • Salt Stoichiometrymodel

Go deeper

Explore Altanserin tartrate

Read the deeper take on agi.asView as markdown